These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28239809)

  • 1. Association between the plasma levels of IMA and coronary atherosclerotic plaque burden and ischemic burden in early phase of non-ST-segment-elevation acute coronary syndromes.
    Turan T; Akyüz AR; Sahin S; Kul S; Yilmaz AS; Kara F; Mentese SO; Aykan AÇ; Demir S; Celik S; Karahan SC
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):576-583. PubMed ID: 28239809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
    Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
    Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department.
    Charpentier S; Ducassé JL; Cournot M; Maupas-Schwalm F; Elbaz M; Baixas C; Juchet H; Lang T; Lauque D
    Acad Emerg Med; 2010 Jan; 17(1):27-35. PubMed ID: 20078436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
    Wudkowska A; Goch J; Goch A
    Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes.
    Bhakthavatsala Reddy C; Cyriac C; Desle HB
    Indian Heart J; 2014; 66(6):656-62. PubMed ID: 25634401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of ischemia-modified albumin in patients with acute coronary syndrome].
    Shen XL; Xing C; Han LL; Lin L; Lin LF; Deng YL; Pu XD; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):814-7. PubMed ID: 18070473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
    Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
    Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Samimi-Fard S; Kaski JC
    Clin Chim Acta; 2008 Feb; 388(1-2):196-9. PubMed ID: 18036561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
    Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
    Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of intravascular ultrasound and angiographic morphology of culprit lesions between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome.
    Takaoka N; Tsujita K; Kaikita K; Hokimoto S; Mizobe M; Nagano M; Horio E; Sato K; Nakayama N; Yoshimura H; Yamanaga K; Komura N; Kojima S; Tayama S; Nakamura S; Ogawa H
    Int J Cardiol; 2014 Feb; 171(3):423-30. PubMed ID: 24433620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
    Pride YB; Mohanavelu S; Zorkun C; Kunadian V; Giugliano RP; Newby LK; Braunwald E; Califf RM; Harrington RA; Gibson CM;
    JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.
    Ukinc K; Eminagaoglu S; Ersoz HO; Erem C; Karahan C; Hacihasanoglu AB; Kocak M
    Endocrine; 2009 Dec; 36(3):425-32. PubMed ID: 19784800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia-modified albumin levels in cerebrovascular accidents.
    Gunduz A; Turedi S; Mentese A; Altunayoglu V; Turan I; Karahan SC; Topbas M; Aydin M; Eraydin I; Akcan B
    Am J Emerg Med; 2008 Oct; 26(8):874-8. PubMed ID: 18926343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of temperature on albumin cobalt binding and its influence on ischemia-modified albumin levels in patients with suspected acute coronary syndrome.
    Hausen BS; Signor C; Kober H; Tatsch E; Pereira RS; Duarte T; Hermes CL; Duarte MM; Moresco RN
    Clin Lab; 2012; 58(1-2):169-72. PubMed ID: 22372361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes.
    Bali L; Cuisset T; Giorgi R; Monserrat C; Quilici J; Carrega L; Mouret JP; Nait-Saidi L; Mielot C; Lambert M; Guieu R; Bonnet JL
    Arch Cardiovasc Dis; 2008 Oct; 101(10):645-51. PubMed ID: 19056071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference of ruptured plaque morphology between asymptomatic coronary artery disease and non-ST elevation acute coronary syndrome patients: an optical coherence tomography study.
    Shimamura K; Ino Y; Kubo T; Nishiguchi T; Tanimoto T; Ozaki Y; Satogami K; Orii M; Shiono Y; Komukai K; Yamano T; Matsuo Y; Kitabata H; Yamaguchi T; Hirata K; Tanaka A; Imanishi T; Akasaka T
    Atherosclerosis; 2014 Aug; 235(2):532-7. PubMed ID: 24953494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification.
    Zhong Y; Wang N; Xu H; Hou X; Xu P; Zhou Z
    Coron Artery Dis; 2012 Dec; 23(8):538-41. PubMed ID: 22936021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome.
    Soylu K; Aksan G; Nar G; Özdemir M; Gülel O; İnci S; Aksakal A; Soylu Aİ; Yılmaz Ö
    Anatol J Cardiol; 2015 Jun; 15(6):450-5. PubMed ID: 25430410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome.
    Mishra B; Pandey S; Niraula SR; Rai BK; Karki P; Baral N; Lamsal M
    J Nepal Health Res Counc; 2018 Mar; 16(1):16-21. PubMed ID: 29717283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.